Búsqueda avanzada

Carrie Brownstein is an Independent Director at Shattuck Labs, Inc. She previously worked as an Executive Director-Clinical Sciences Oncology at Regeneron Pharmaceuticals, Inc. and as a Senior Director-Medical at Roche Pharmaceuticals, Inc. From 2017 to 2020, she was the VP-Global Clinical Research & Development at Celgene Corp.
She was also the Chief Medical Officer at Cellectis SA from 2020 to 2022 and at Zentalis Pharmaceuticals, Inc. from 2022 to 2024.
Brownstein received her undergraduate degree from the University of Michigan and her doctorate from Tufts University School of Medicine.

Lawrence Brownstein is Executive of Corporate Development for CRI Worldwide LLC.
Previously, he worked at HealthSouth Corp., Advanta Corp., and NovaCare.
Mr. Brownstein began his professional career as an Entrepreneur.
He has over 15 years of management experience.
Mr. Brownstein received a Bachelor of Arts degree from Northwestern University and an MBA from Pennsylvania State University.

Michael J.
Brownstein is currently the Vice President-Drug Development at Azevan Pharmaceuticals, Inc. He previously held positions as Co-Chairman at N-Gene Research Laboratories, Laboratory Chief & Scientific Director at National Institute of Mental Health, Chief Scientific Officer at Exponential Biotherapies, Genetics Laboratory Chief at National Institutes of Health, and Genetics Laboratory Chief at National Human Genome Research Institute.
Brownstein received his undergraduate degree from The Trustees of Columbia University in The City of New York and his doctorate from The University of Chicago and the University of Lund.

Ms. Linda S.
Brownstein is Partner at Footprint Ventures.
She is on the Board of Directors at Spring Leaf Retail Pvt Ltd., Hector Beverages Pvt Ltd.
and NatureBridge.

Evan Brownstein is currently the Senior Vice President of Marketing & Communications at HealthPlan Services, Inc. He has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Swarthmore College.

Andrew Brownstein is currently working as a Sector Head at Sunriver Management LLC since 2015.
Prior to this, he worked as a Principal at Eton Park Capital Management LP in 2009-2010.
He also worked as an Analyst at The Blackstone Group, Inc. (Illinois) in 2007-2009 and as an Analyst at Soroban Capital Partners LP.
Mr. Brownstein completed his undergraduate degree from the University of Pennsylvania in 2007.

Iris N.
Brownstein is a member of the Philadelphia Bar Association and the Pennsylvania State Bar Association.
She previously worked as a Principal at CIGNA Property & Casualty, an Attorney at Chubb Group, and as the General Counsel & Corporate Secretary at Health Advocate, Inc. She received her undergraduate degree from Boston University and her graduate degree from the University of Miami School of Law.